Related Experiment Video
Updated: Jun 11, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Functional expression of carnitine/organic cation transporter OCTN1/SLC22A4 in mouse small intestine and liver
Tomoko Sugiura1, Sayaka Kato, Takuya Shimizu
1Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kakuma-machi, Kanazawa, Japan.
Abstract:
Carnitine/organic cation transporter (OCTN1/SLC22A4) accepts various therapeutic agents as substrates in vitro and is expressed ubiquitously, although its function in most organs has not yet been examined. The purpose of the present study was to evaluate functional expression of OCTN1 in small intestine and liver, using octn1 gene knockout [octn1(-/-)] mice. After oral administration of [(3)H]ergothioneine ([(3)H]ERGO), a typical substrate of OCTN1, the amount of [(3)H]ERGO remaining in the small intestinal lumen was much higher in octn1(-/-) mice than in wild-type mice. In addition, uptake of [(3)H]ERGO by human embryonic kidney 293 cells heterologously expressing OCTN1 gene product and uptake of [(3)H]ERGO at the apical surface of intestinal everted sacs from wild-type mice were inhibited by OCTN1 substrates, tetraethylammonium and verapamil. Immunohistochemical analysis revealed that OCTN1 is localized on the apical surface of small intestine in mice and humans. These results suggest that OCTN1 is responsible for small intestinal absorption of [(3)H]ERGO. However, the plasma concentration of [(3)H]ERGO after oral administration was higher in octn1(-/-) mice than in wild-type mice, despite the lower absorption in octn1(-/-) mice. This was probably because of efficient hepatic uptake of [(3)H]ERGO, as revealed by integration plot analysis; the uptake clearance was close to the hepatic plasma flow rate. The uptake of [(3)H]ERGO by isolated hepatocytes was minimal, whereas [(3)H]ERGO uptake was observed in isolated nonparenchymal cells. This finding is consistent with immunostaining of OCTN1 in liver sinusoids. Thus, our results indicate that OCTN1 is functionally expressed in nonparenchymal liver cells.
Insights
The carnitine/organic cation transporter 1 (OCTN1) facilitates ergothioneine absorption in the small intestine. OCTN1 is also present in liver non-parenchymal cells, influencing ergothioneine
Area of Science:
- Pharmacology
- Molecular Biology
- Physiology
Background:
- The carnitine/organic cation transporter 1 (OCTN1/SLC22A4) is known to transport various drugs.
- Its precise physiological function in organs like the small intestine and liver remains largely uncharacterized.
- Understanding OCTN1's role is crucial for drug delivery and nutrient absorption studies.
Purpose of the Study:
- To investigate the functional expression and role of OCTN1 in the small intestine and liver.
- To elucidate the contribution of OCTN1 to the absorption and distribution of its substrate, ergothioneine (ERGO).
Main Methods:
- Utilized octn1 gene knockout (octn1(-/-)) mice and wild-type littermates.
- Administered radiolabeled [(3)H]ergothioneine ([(3)H]ERGO) orally and intravenously.
- Performed in vitro uptake studies using cell lines and isolated intestinal/hepatic cells.
- Conducted immunohistochemical analysis for OCTN1 localization.
Main Results:
- octn1(-/-) mice showed significantly higher amounts of [(3)H]ERGO remaining in the small intestinal lumen post-oral administration.
- Uptake of [(3)H]ERGO in intestinal tissues and OCTN1-expressing cells was inhibited by known OCTN1 substrates.
- Immunohistochemistry confirmed OCTN1 localization on the apical surface of the small intestine in both mice and humans.
- Plasma concentrations of [(3)H]ERGO were higher in octn1(-/-) mice, suggesting efficient hepatic uptake.
- OCTN1 was found to be functionally expressed in non-parenchymal liver cells, not hepatocytes.
Conclusions:
- OCTN1 plays a significant role in the intestinal absorption of ergothioneine.
- OCTN1 is functionally expressed in the non-parenchymal cells of the liver, contributing to hepatic uptake.
- These findings highlight OCTN1's importance in both intestinal absorption and hepatic disposition of ergothioneine.
Related Concept Videos
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Membrane Transporters
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Hepatic Drug Clearance: Role of Transporters
